Technology | Treatment Planning | February 17, 2016

RaySearch Releases RayStation 5 with Support for Carbon Ion Radiotherapy

Latest release also includes Plan Explorer to generate a large number of treatment plans for an individual patient

RaySearch Labs, RayStation 5 release, carbon ion radiation therapy

February 17, 2016 — RaySearch Laboratories AB announced that version 5 of the RayStation treatment planning system has been released for clinical use in the United Kingdom, Australia and New Zealand. The latest version of the platform is scheduled for release in most major markets during the first half of 2016.

RayStation 5 features carbon ion treatment planning, which represents the most advanced form of radiation therapy, and Plan Explorer, a treatment planning tool that allows clinics to maximize delivery efficiency and plan quality for every individual patient treatment.

Carbon ion therapy is a form of particle therapy that has several clinical advantages. As for other types of particle therapy, the depth of the dose deposition can be precisely controlled, which allows for improved sparing of healthy tissues. Additionally, carbon ions have an increased relative biological effectiveness (RBE) compared with other types of radiation. 

An important part of the support for carbon ion treatment planning in RayStation 5 is the precise modeling of RBE, which has been developed in collaboration with the GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt, Germany. RBE modeling is one of several examples of technologies that will be applicable also to other types of treatment planning in RayStation. The first clinics to adopt this new planning technology are MedAustron in Austria and Centro Nazionale di Adroterapia Oncologica (CNAO) in Italy.

Plan Explorer is a tool that is based on the capability to automatically generate a large number of treatment plans for an individual patient that span defined combinations of treatment techniques and machines. It also provides efficient means to filter and browse among plan candidates to find the most desired one. This makes it possible to ensure that every radiation treatment is delivered with the highest possible efficiency, with an optimal combination of treatment technique and machine. It will enable clinics to save planning time and to maximize the use of their treatment machine resources.

RayStation 5 also features many new additions such as robust optimization based on 4-D computed tomography (CT) images and unlimited patient data storage. The inclusion of 4-D CT images in the robust optimization process addresses situations where there is significant relative motion of internal organs, such as in the thorax during free breathing.

In order to manage the ever-increasing data volumes associated with modern imaging techniques and high resolution calculations, RayStation 5 allows a more flexible configuration of multiple parallel databases and gradual archiving. This streamlines the upgrade process. RayStation 5 also adds a rich palette of significant improvements within general planning and patient modeling, such as treatment case level, volume rendering, smart brush contouring, side-by-side contouring, improved 3-D conformal radiation therapy (CRT) planning, improvements to plan printouts, plan protocols and scripting and the addition of a module for virtual simulation. As a final point, the graphical user interface has been reworked to further enhance the user experience.

For more information: www.raysearchlabs.com

Related Content

Follow up results on first multicenter trial to report outcomes of salvage low dose radiotherapy brachytherapy after external beam radiotherapy for prostate cancer
News | Prostate Cancer | October 30, 2020
October 30, 2020 — Researchers involved in the...
Interoperability between Brainlab and Accuray planning systems using Snke OS, an enterprise health tech platform
News | Treatment Planning | October 29, 2020
October 29, 2020 — Accuray Incorporated, a pioneer in the robotic stereotactic radiosurgery (...
Vinai Gondi, M.D., the Director of Research at the Northwestern Medicine Chicago Proton Center, Co-director of the Brain Tumor Center at Northwestern Medicine Cancer Center, Warrenville, and lead author of the NRG-BN001 abstract.

Vinai Gondi, M.D., director of research at the Northwestern Medicine Chicago Proton Center, co-director of the Brain Tumor Center at Northwestern Medicine Cancer Center, Warrenville, and lead author of the NRG-BN001 abstract.

News | Intensity Modulated Radiation Therapy (IMRT) | October 27, 2020
October 27, 2020 — A...
"Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4-15 brain metastases: A phase III randomized controlled trial" was presented by Jing Li, M.D., The University of Texas MD Anderson Cancer Center, at ASTRO20
News | Stereotactic Body Radiation Therapy (SBRT) | October 26, 2020
October 26, 2020 — Results of a new randomized phase III trial suggest that...
"Stereotactic ablative fractionated radiotherapy versus radiosurgery for oligometastatic neoplasia to the lung: A randomised phase II trial," presented by Shankar Siva, Ph.D., Peter MacCallum Cancer Centre, was presented at ASTRO20
News | Stereotactic Body Radiation Therapy (SBRT) | October 26, 2020
October 26, 2020 — A new study, conducted across 13 medical centers in Australia and New Zealand, strengthens the cas
"Initial report of a randomized trial comparing conventional- vs conventional plus fluciclovine (18F) PET/CT imaging-guided post-prostatectomy radiotherapy for prostate cancer" was presented by Ashesh Jani, M.D., Winship Cancer Institute of Emory University, at ASTRO20
News | PET Imaging | October 26, 2020
October 26, 2020 — Adding the advanced PET radiotracer...
A randomized phase II/III study comparing 24Gy in 2 stereotactic body radiotherapy (SBRT) fractions versus 20Gy in 5 conventional palliative radiotherapy (CRT) fractions for patients with painful spinal metastases was presented by Arjun Sahgal, M.D., University of Toronto, today at ASTRO20
News | Radiation Therapy | October 26, 2020
October 26, 2020 — A new study shows using fewer and higher doses of high-precision...
Nearly 40 MRIdian-focused presentations will be part of the ASTRO Scientific Sessions
News | Magnetic Resonance Imaging (MRI) | October 26, 2020
October 26, 2020 — ViewRay, Inc. announced that the company's MRIdian Linac MRI-guided radiation therapy system will
Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases, suggests a new study from Penn Medicine. In a retrospective trial of more than 200 patients, mini-strokes were significantly less common among patients who underwent proton therapy versus conventional photon-based radiation therapy. Proton therapy patients also experienced fewer heart attacks.
News | Proton Therapy | October 25, 2020
October 25, 2020 — Treating lung cancer patients with prot...